How Much Did MycoTechnology Raise?
Funding & Key Investors

MycoTechnology has successfully secured a significant capital injection, bringing its total funding to $206.4M. This latest strategic investment, totaling $85M, underscores the company's pivotal role in the evolving foodtech landscape. By leveraging its proprietary mycelia fermentation technology, the firm continues to attract high-profile backing from institutional investors and industry leaders committed to sustainable food innovation.

The company's trajectory, marked by consistent growth since its inception in 2013, reflects a maturation from early-stage development to a sophisticated enterprise-level player. This recent financing round serves as a testament to the market's confidence in MycoTechnology's ability to scale its unique flavor modulation and protein-based solutions globally.

What is MycoTechnology?

MycoTechnology
ManufacturingFood & BeverageBusiness Services

Based in Aurora, Colorado, MycoTechnology is a pioneer in the application of mushroom mycelia to address critical challenges within the global food supply chain. The company operates at the intersection of biotechnology and food science, utilizing natural fermentation processes to create high-value ingredients. Its core product portfolio includes ClearIQ, a flavor modulation tool designed to enhance nutrient density while reducing salt and sugar, and FermentIQ, a line of functional plant proteins. By transforming mycelia into scalable food solutions, MycoTechnology positions itself as a key enabler for clean-label and sustainable food production, serving a diverse range of applications across the industry.

How much funding has MycoTechnology raised?

MycoTechnology has raised a total of $206.4M across 7 funding rounds:

2014

Debt

$1.1M

Debt

$100K

2015

Series A

$9.2M

2017

Series B

$42M

2019

Series C

$30M

2020

Series D

$39M

2022

Series E

$85M

Debt (2014): $1.1M with participation from Advance Ventures

Debt (2014): $100K led by Advance Ventures

Series A (2015): $9.2M supported by S2G Ventures, Seventure Partners, and Middleland Capital

Series B (2017): $42M featuring Middleland Capital, Health for Life Capital, S2G Ventures, Ajinomoto Co., Inc., and Continental Grain Company

Series C (2019): $30M backed by Middleland MT Holdings, DNS-Hiitake, ADM Capital, TML-Invest S.à r.l., Tysons Ventures, S2G Ventures, Bunge Ventures, Continental Grain Company, and Eighteen94 Capital

Series D (2020): $39M with participation from SPC, Middleland Capital, Cibus Investments, S2G Ventures, eighteen94 Capital, Bunge Ventures, CGC, Rich Products Ventures, Greenleaf Foods, Tyson Ventures, Seventure Partners, and Evolution Partners

Series E (2022): $85M led by Tysons Ventures and Maple Leaf Foods

Key Investors in MycoTechnology

S2G Ventures

S2G Ventures is a multi-stage food and agriculture venture fund that invests in entrepreneurs whose products and services meet the shifting demands for healthy and sustainable food across the entire supply chain.

Middleland Capital

Middleland Capital is a thematic venture capital fund focused on catalyzing global change in the food and health sectors, specializing in innovative foodtech and agtech investments.

Continental Grain Company

Continental Grain Company is a global investor, owner, and operator of companies across the food, agribusiness, and commodities spectrum, with a history dating back to 1813.

What's next for MycoTechnology?

With the successful closure of this latest funding round, MycoTechnology is well-positioned to accelerate its operational expansion and deepen its market penetration. The strategic focus will likely center on scaling production capacity to meet the rising demand for functional, plant-based ingredients. Furthermore, the company is expected to continue its recruitment efforts, bolstering its team of employee-shareholders to drive further innovation in mycelia-based applications. As the food industry faces increasing pressure to adopt sustainable practices, MycoTechnology's ability to bridge the gap between natural fermentation and industrial-scale food production will be central to its long-term growth strategy and competitive advantage.

See full MycoTechnology company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingTelecommunication EquipmentSecurity SoftwareSoftware
ManufacturingPulp & PaperPlastic, Packaging & ContainersTextiles & Apparel
Cosmetics, Beauty Supply & Personal Care ProductsManufacturingSpa and Salon ManagementConsumer Services
Industrial Machinery & EquipmentManufacturingAutomobile Parts StoresAutomotive PartsRetail

Frequently Asked Questions Regarding MycoTechnology Financial Insights

What are the most recent funding rounds that MycoTechnology has completed, and what were the funding rounds?
MycoTechnology has recently completed 3 funding rounds: Series E on Mar 30, 2022, Series D on Jun 12, 2020, Series C on Jan 30, 2019.
What is the total amount of funding MycoTechnology has raised to date?
MycoTechnology has raised a total of $206.4M in funding to date.
How many funding rounds has MycoTechnology completed?
MycoTechnology has completed 3 funding rounds.
How much funding did MycoTechnology raise in its most recent funding round?
MycoTechnology raised $85M in its most recent funding round.
Who are the lead investors in MycoTechnology's latest funding round?
The lead investor in MycoTechnology's latest funding round was Tysons Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in MycoTechnology's history?
The largest funding round in MycoTechnology's history was $85M.
See more information about MycoTechnology